NURECA
Back to All Ratios
|
NURECA Last 5 Year Sales/Fixed Asset History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Sales/Fixed Asset(x) | 9.09 | 10.38 | 34.28 | 89.50 | 118.31 |
What is the latest Sales/Fixed Asset ratio of NURECA ?
Year | Sales/Fixed Asset |
---|---|
Mar2024 | 9.09 |
Mar2023 | 10.38 |
Mar2022 | 34.28 |
Mar2021 | 89.50 |
Mar2020 | 118.31 |
How is Sales/Fixed Asset of NURECA Trending?
Years | Sales/Fixed Asset | % Change | |
---|---|---|---|
Mar2024 | 9.09 | -12.43 | |
Mar2023 | 10.38 | -69.72 | |
Mar2022 | 34.28 | -61.70 | |
Mar2021 | 89.5 | -24.35 | |
Mar2020 | 118.31 | - |
Other Financial Ratios of NURECA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Sales/Fixed Asset ratio of peers of NURECA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NURECA | ₹281.1 Cr | -2.5% | 2.5% | -22.9% | Stock Analytics | |
POLY MEDICURE | ₹26,321.9 Cr | -8.9% | 0.3% | 74.6% | Stock Analytics | |
PREVEST DENPRO | ₹686.9 Cr | -5.5% | 5.9% | 37.7% | Stock Analytics |
NURECA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NURECA | -2.5% |
2.5% |
-22.9% |
SENSEX | -5% |
0.6% |
9.2% |
You may also like the below Video Courses